We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-6.57%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$992B
AUM Growth
-$120B
Cap. Flow
-$16.9B
Cap. Flow %
-1.7%
Top 10 Hldgs %
27.94%
Holding
3,085
New
108
Increased
1,637
Reduced
1,059
Closed
107

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$4.45B
2
JPM icon
JPMorgan Chase
JPM
+$2.22B
3
TEAM icon
Atlassian
TEAM
+$2.08B
4
NVDA icon
NVIDIA
NVDA
+$1.81B
5
AAPL icon
Apple
AAPL
+$1.67B

Sector Composition

Rank Sector Weight
1 Technology 26.79%
2 Healthcare 17.19%
3 Consumer Discretionary 15.16%
4 Financials 10.74%
5 Communication Services 10.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
U icon
926
Unity
U
$20.2B
$56.6M 0.01%
570,187
-100,275
-15% -$10.4M
KR icon
927
Kroger
KR
$35.1B
$56.4M 0.01%
983,244
-63,010
-6% -$3.13M
HR icon
928
Healthcare Realty
HR
$6.58B
$56.2M 0.01%
1,794,440
-84,544
-4% -$2.66M
THR
929
DELISTED
Thermon Group Holdings
THR
$56.2M 0.01%
3,471,295
-31,394
-0.9% -$546K
TWST icon
930
Twist Bioscience
TWST
$7.86B
$56.2M 0.01%
1,137,905
+222,676
+24% +$12.3M
TXRH icon
931
Texas Roadhouse
TXRH
$13.6B
$56.2M 0.01%
670,829
+1,623
+0.2% +$139K
O icon
932
Realty Income
O
$59.6B
$56.1M 0.01%
809,568
-326,595
-29% -$22.2M
TKR icon
933
Timken Company
TKR
$9.1B
$56.1M 0.01%
923,585
-501,338
-35% -$33.3M
PACB icon
934
Pacific Biosciences
PACB
$357M
$55.5M 0.01%
6,104,093
+270,289
+5% +$3.11M
ADV icon
935
Advantage Solutions
ADV
$423M
$55.5M 0.01%
348,178
+879
+0.3% +$152K
SBCF icon
936
Seacoast Banking Corp of Florida
SBCF
$3.48B
$55.4M 0.01%
1,581,981
-2,999,101
-65% -$109M
AZTA icon
937
Azenta
AZTA
$1.49B
$55.3M 0.01%
667,394
+4,906
+0.7% +$421K
KTOS icon
938
Kratos Defense & Security Solutions
KTOS
$11.8B
$55M 0.01%
2,683,305
-44,399
-2% -$810K
EPAM icon
939
EPAM Systems
EPAM
$5.24B
$54.4M 0.01%
183,471
-4,544
-2% -$1.78M
NSP icon
940
Insperity
NSP
$2.05B
$54.4M 0.01%
541,889
+8,459
+2% +$843K
BOAC.U
941
DELISTED
Bluescape Opportunities Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-half of one redeemable warrant
BOAC.U
$54.3M 0.01%
5,426,731
+676
+0% +$6.79K
BROS icon
942
Dutch Bros
BROS
$8.93B
$53.9M 0.01%
975,158
-111,698
-10% -$5.7M
GMAB icon
943
Genmab
GMAB
$19.3B
$53.8M 0.01%
1,488,035
-214,996
-13% -$7.38M
GRAB icon
944
Grab
GRAB
$15.1B
$53.1M 0.01%
15,185,714
-13,282,771
-47% -$67.2M
FIX icon
945
Comfort Systems
FIX
$60.8B
$52.9M 0.01%
594,464
+9,682
+2% +$869K
CW icon
946
Curtiss-Wright
CW
$25.4B
$52.9M 0.01%
352,179
-21,334
-6% -$3.04M
PFGC icon
947
Performance Food Group
PFGC
$16.4B
$52.6M 0.01%
1,033,239
+377,605
+58% +$18.5M
AME icon
948
Ametek
AME
$58.7B
$52.5M 0.01%
394,542
-16,927
-4% -$2.27M
ABG icon
949
Asbury Automotive
ABG
$3.78B
$52.5M 0.01%
327,898
+8,644
+3% +$1.51M
HWKN icon
950
Hawkins
HWKN
$2.67B
$52.3M 0.01%
1,139,141
-6,504
-0.6% -$274K

Similar funds

T. Rowe Price Associates's Q1 2022 Portfolio in Review

As of Q1 2022, T. Rowe Price Associates held 3,085 positions worth $992B, down 11% from $1.11T the previous quarter. Its ten largest holdings account for 28% of the portfolio.

T. Rowe Price Associates's Q1 2022 filing shows 108 new, 1,637 increased, 1,059 reduced and 107 closed positions. Its largest new stake was Nutrien: 6,143,560 shares worth $639M. The largest sale was Alphabet (Google) Class C, an estimated $3.24B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q1 2022 buy was Nutrien: 6,143,560 shares worth $639M.
  • T. Rowe Price Associates added most to Tesla in Q1 2022, an estimated $4.45B increase.
  • T. Rowe Price Associates's biggest Q1 2022 reduction was Alphabet (Google) Class C, cutting an estimated $3.24B.
  • T. Rowe Price Associates fully exited Xilinx Inc in Q1 2022, selling an estimated $481M.
  • T. Rowe Price Associates's ten largest holdings make up 28% of its $992B portfolio in Q1 2022.
  • T. Rowe Price Associates opened 108 new positions and closed 107 in Q1 2022.
  • T. Rowe Price Associates's portfolio value fell 11% quarter-over-quarter to $992B.

Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.